Janan Jona

865 total citations
21 papers, 625 citations indexed

About

Janan Jona is a scholar working on Pharmaceutical Science, Materials Chemistry and Spectroscopy. According to data from OpenAlex, Janan Jona has authored 21 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 9 papers in Materials Chemistry and 8 papers in Spectroscopy. Recurrent topics in Janan Jona's work include Drug Solubulity and Delivery Systems (9 papers), Crystallization and Solubility Studies (8 papers) and Analytical Chemistry and Chromatography (6 papers). Janan Jona is often cited by papers focused on Drug Solubulity and Delivery Systems (9 papers), Crystallization and Solubility Studies (8 papers) and Analytical Chemistry and Chromatography (6 papers). Janan Jona collaborates with scholars based in United States, New Zealand and Japan. Janan Jona's co-authors include Karthik Nagapudi, Kaneto Uekama, Roger A. Rajewski, Valentino J. Stella, Kazuto Okimoto, Tian Wu, Lei Zhu, Y.-H. Kiang, Anwar Hussain and Lewis W. Dittert and has published in prestigious journals such as Analytical Biochemistry, Antimicrobial Agents and Chemotherapy and International Journal of Pharmaceutics.

In The Last Decade

Janan Jona

20 papers receiving 602 citations

Peers

Countries citing papers authored by Janan Jona

Since Specialization

Citations

This map shows the geographic impact of Janan Jona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janan Jona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janan Jona more than expected).

Fields of papers citing papers by Janan Jona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janan Jona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janan Jona. The network helps show where Janan Jona may publish in the future.

Co-authorship network of co-authors of Janan Jona

This figure shows the co-authorship network connecting the top 25 collaborators of Janan Jona. A scholar is included among the top collaborators of Janan Jona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janan Jona. Janan Jona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Conformational Isomerism in Solid State of AMG 853—Structure Studies Using Solid-State Nuclear Magnetic Resonance and X-ray Diffraction 2015 ·Journal of Pharmaceutical Sciences ·(unknown), Karthik Nagapudi, Tian Wu, Matthew L. Peterson, Janan Jona, Richard J. Staples, Peter W. Stephens	1
2	High-throughput 96-well solvent mediated sonic blending synthesis and on-plate solid/solution stability characterization of pharmaceutical cocrystals 2012 ·International Journal of Pharmaceutics ·Luu Van Boi, Janan Jona, Mary K. Stanton, Matthew L. Peterson, Henry Morrison, Karthik Nagapudi, (unknown)	13
3	Crystal structure study and investigation of solid-state cyclization for AMG 222, a channel hydrate 2012 ·International Journal of Pharmaceutics ·Y.-H. Kiang, Karthik Nagapudi, Jodi Liu, Richard J. Staples, Janan Jona	6
4	Manufacture and Performance Evaluation of a Stable Amorphous Complex of an Acidic Drug Molecule and Neusilin 2011 ·Journal of Pharmaceutical Sciences ·(unknown), César Medina, Dominick Daurio, Fernando Alvarez‐Núñez, Janan Jona, Eric J. Munson, Karthik Nagapudi	35
5	Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency 2011 ·Bioorganic & Medicinal Chemistry Letters ·Wenyuan Qian, Jian Jeffrey Chen, (unknown), (unknown), Jiawang Zhu, Kaustav Biswas, (unknown), Randall W. Hungate, Leyla Arik, (unknown), Gondi Kumar, (unknown), Janan Jona, (unknown), (unknown)	7
6	Fast Surface Crystallization of Amorphous Griseofulvin Below T g 2010 ·Pharmaceutical Research ·Lei Zhu, Janan Jona, Karthik Nagapudi, Tian Wu	94
7	A Quantitative Kinetic Study of Polysorbate Autoxidation: The Role of Unsaturated Fatty Acid Ester Substituents 2009 ·Pharmaceutical Research ·(unknown), (unknown), Matthew Noestheden, (unknown), Bruce A. Kerwin, Janan Jona, Dražen Ostović, Darren L. Reid	69
8	Multiple approaches to pharmaceutical polymorphism investigation—A case study 2009 ·European Journal of Pharmaceutical Sciences ·Haitao Li, Y.-H. Kiang, Janan Jona	22
9	Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using¹⁹F solid-state NMR and powder X-ray diffraction 2009 ·Drug Development and Industrial Pharmacy ·Jodi Liu, Karthik Nagapudi, Y.-H. Kiang, (unknown), Janan Jona	16
10	Quantitative determination of solid-state forms of a pharmaceutical development compound in drug substance and tablets 2008 ·International Journal of Pharmaceutics ·Yong Xie, (unknown), Henry Morrison, (unknown), Janan Jona, (unknown), Nina S. Cauchon	25
11	Crystal structure, crystal morphology, and surface properties of an investigational drug 2008 ·International Journal of Pharmaceutics ·Y.-H. Kiang, (unknown), Richard J. Staples, Janan Jona	23
12	Amorphous Active Pharmaceutical Ingredients in Preclinical Studies: Preparation, Characterization, and Formulation 2008 ·Current Bioactive Compounds ·Karthik Nagapudi, Janan Jona	37
13	Multi-criteria analysis for the sizing and selection of circuit breakers in power systems 2007 ·Janan Jona, (unknown)	1
14	Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa 2006 ·Bioorganic & Medicinal Chemistry Letters ·Yunlong Li, John M. Fevig, Joseph Cacciola, (unknown), Karen A. Rossi, Janan Jona, Robert M. Knabb, Joseph M. Luettgen, Pancras C. Wong, Stephen A. Bai, Ruth R. Wexler, Patrick Y. S. Lam	24
15	High‐throughput logP measurement using parallel liquid chromatography/ultraviolet/mass spectrometry and sample‐pooling 2002 ·Rapid Communications in Mass Spectrometry ·Yining Zhao, Janan Jona, David Chow, Haojing Rong, David Semin, Xiaoyang Xia, Roger Zanon, (unknown), (unknown)	42
16	DPC 681 and DPC 684: Potent, Selective Inhibitors of Human Immunodeficiency Virus Protease Active against Clinically Relevant Mutant Variants 2001 ·Antimicrobial Agents and Chemotherapy ·Robert F. Kaltenbach, George L. Trainor, Daniel P. Getman, (unknown), Sena Garber, Beverly C. Cordova, Lee T. Bacheler, Susan Jeffrey, (unknown), (unknown), Ronald M. Klabe, Sharon Diamond, Marc H. Davies, (unknown), Janan Jona, Susan Erickson‐Viitanen	8
17	Competitive inhibitory effect of external nucleophile concentration on intramolecular O- to N-acylation in O-acetylsalicylamide 2000 ·AAPS PharmSciTech ·Anwar Hussain, Janan Jona, Peter A. Crooks	1
18	Applications of modulated differential scanning calorimetry in preformulation studies 1999 ·Journal of Pharmaceutical and Biomedical Analysis ·Shelley R. Rabel, Janan Jona, Michael B. Maurin	24
19	The Interaction of Charged and Uncharged Drugs with Neutral (HP-β-CD) and Anionically Charged (SBE7-β-CD) β-Cyclodextrins 1996 ·Pharmaceutical Research ·Kazuto Okimoto, Roger A. Rajewski, Kaneto Uekama, Janan Jona, Valentino J. Stella	133
20	Chloramine-T in Radiolabeling Techniques II. A Nondestructive Method for Radiolabeling Biomolecules by Halogenation 1995 ·Analytical Biochemistry ·Anwar Hussain, Janan Jona, (unknown), Lewis W. Dittert	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact